š° Be Limited News
Page 2 - Be Limited News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Be Limited. Real-time updates on events, politics, business and more.
December 16, 2022
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
December 16, 2022
Get latest articles and stories on India at LatestLY. Streptococcus pneumonia infection remains one of the leading causes of death among children under five in India and developing countries. BEs PCV14 Vaccine will help prevent invasive pneumococcal infection and save millions of lives worldwide. PCV14 may be administered to infants of 6, 10 and 14 weeks of age, Biological E said. India News | Biological E Gets DCGIs Nod to Manufacture, Market 14-valent Pneumococcal Conjugate Vaccine.
December 16, 2022
Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine, (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. ...
September 1, 2022
Hyderabad:Biological E. Limited (BE), the Hyderabad-based vaccine's manufacturer, announced today that the Subject Expert Committee of CDSCO reviewed and approved the Phase 3 infants clinical trial data and recommended for the manufacture of its 14-valent pediatric vaccine (investigational pneumococcal polysaccharide conjugate vaccine PCV14) against S. pneumonia infection in
September 1, 2022
Vaccine manufacturer Biological E. Limited (BE) announced on Thursday that the Subject Expert Committee of Central Drugs Standard Control Organization (CDSCO) has approved the Phase 3 infants clinical trial data and recommended for manufacture ...
September 1, 2022
Hyderabad, Sep 1 (IANS) Vaccine manufacturer Biological E. Limited (BE) announced on Thursday that the Subject Expert Committee of Central Drugs Standard
August 15, 2022
Acclaimed national publication Fast Company has announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made t
August 10, 2022
Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological Eās CORBEVAX as a heterologous booster for adults above 18 yrs old
August 9, 2022
/PRNewswire/ -- Fast Company today announced its 14th annual list of the Most Creative People in Business, which recognizes individuals making a cultural...
August 8, 2022
Stay connected with Business News This Week for business news, news this week, news headlines, business news, health, education, startups